logo
explain how to read the page

The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers 1
  • 1
    Summy, Mohanjit Kaur
    Born in August 1958
    Individual (3 offsprings)
    Officer
    2014-12-17 ~ now
    OF - Director → CIF 0
    Ms Mohanjit Kaur Summy
    Born in August 1958
    Individual (3 offsprings)
    Person with significant control
    2017-02-01 ~ 2019-07-01
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
parent relation
Company in focus

SAFFRON PHARMA CONSULTING LTD

Period: 2014-12-17 ~ now
Company number: 09357972
Registered name
SAFFRON PHARMA CONSULTING LTD - now
Standard Industrial Classification
74909 - Other Professional, Scientific And Technical Activities N.e.c.
Brief company account
Property, Plant & Equipment
23,827 GBP2024-12-31
16,924 GBP2023-12-31
Debtors
66,891 GBP2024-12-31
153,360 GBP2023-12-31
Cash at bank and in hand
480,012 GBP2024-12-31
437,116 GBP2023-12-31
Current Assets
546,903 GBP2024-12-31
590,476 GBP2023-12-31
Creditors
Current
81,628 GBP2024-12-31
66,585 GBP2023-12-31
Net Current Assets/Liabilities
465,275 GBP2024-12-31
523,891 GBP2023-12-31
Total Assets Less Current Liabilities
489,102 GBP2024-12-31
540,815 GBP2023-12-31
Equity
Called up share capital
4 GBP2024-12-31
4 GBP2023-12-31
Retained earnings (accumulated losses)
489,098 GBP2024-12-31
540,811 GBP2023-12-31
Equity
489,102 GBP2024-12-31
540,815 GBP2023-12-31
Average Number of Employees
22024-01-01 ~ 2024-12-31
22023-01-01 ~ 2023-12-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
38,253 GBP2024-12-31
24,362 GBP2023-12-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
14,426 GBP2024-12-31
7,438 GBP2023-12-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Plant and equipment
6,988 GBP2024-01-01 ~ 2024-12-31
Property, Plant & Equipment
Plant and equipment
23,827 GBP2024-12-31
16,924 GBP2023-12-31
Trade Debtors/Trade Receivables
Amounts falling due within one year, Current
30,360 GBP2023-12-31
Other Debtors
Current, Amounts falling due within one year
66,891 GBP2024-12-31
Amounts falling due within one year, Current
123,000 GBP2023-12-31
Debtors
Current, Amounts falling due within one year
66,891 GBP2024-12-31
Amounts falling due within one year, Current
153,360 GBP2023-12-31
Other Taxation & Social Security Payable
Current
78,250 GBP2024-12-31
63,795 GBP2023-12-31
Other Creditors
Current
3,378 GBP2024-12-31
2,790 GBP2023-12-31

  • SAFFRON PHARMA CONSULTING LTD
    Info
    Registered number 09357972
    C/o Hillier Hopkins Llp First Floor, Radius House, 51 Clarendon Road, Watford, Hertfordshire WD17 1HP
    PRIVATE LIMITED COMPANY incorporated on 2014-12-17 (11 years 5 months). The status of the company number is Active.
    The last date of confirmation statement was made at 2025-11-19
    CIF 0
child relation
Offspring entities and appointments 0
  • Not found in our database.

The content of this website is protected by AgonGuard.

© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.

Contains public sector information retrieved at 22 April 2026 and licensed under the Open Government Licence v3.0.